Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.
Saved in:
| Title: | Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations. |
|---|---|
| Authors: | Ślusarczyk A; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland., Baboudjian M; Department of Urology, APHM, North Academic Hospital, Marseille, France., Zapała P; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland., Yanagisawa T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Miszczyk M; IIIrd Radiotherapy and Chemotherapy Department, Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa, Poland., Chlosta M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Jagiellonian University in Cracow, Kraków, Poland., Krumpoeck P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Moschini M; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Gandaglia G; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Ploussard G; Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France., Rivas JG; Department of Urology, Clinico San Carlos Hospital, Madrid, Spain., Życzkowski M; Department of Urology, Medical University of Silesia, Zabrze, Poland., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada., Radziszewski P; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland., Leapman MS; Department of Urology, Yale School of Medicine, New Haven, Connecticut, USA., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Weill Cornell Medical College, New York, New York, USA.; Department of Urology, University of Texas Southwestern, Dallas, Texas, USA.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Urology, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan., Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Medical University of Silesia, Zabrze, Poland. |
| Source: | The Prostate [Prostate] 2023 Nov; Vol. 83 (15), pp. 1504-1515. Date of Electronic Publication: 2023 Aug 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0045 |
|---|---|
| DOI: | 10.1002/pros.24609 |
